Hong Kong stocks fluctuate | Luopu Biotechnology (02157.HK) surged more than 13% in the morning, institutions pointed out that MRG006A is expected to promote precise treatment of liver cancer.

According to the Securities Times app, Luopu Biology (02157.HK) rose over 13% in the morning, up 12.57% as of the time of publication, to 4.03 Hong Kong dollars, with a turnover of 36.3149 million Hong Kong dollars.